Evidence map›Paper›PMID 39926042›Full record

ArticleIJID regions2025

Niloofar Ghahari, Arezoo Mirzaei, Bahram Nasr Esfahani, Sharareh Moghim

Abstract read
In one paragraph

Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Niloofar GhahariDepartment of Bacteriology and Virology, Faculty of Medicine, Isfahan University of Medical Science, Isfahan, Iran.
Arezoo MirzaeiDepartment of Bacteriology and Virology, Faculty of Medicine, Isfahan University of Medical Science, Isfahan, Iran.
Bahram Nasr EsfahaniDepartment of Bacteriology and Virology, Faculty of Medicine, Isfahan University of Medical Science, Isfahan, Iran.
Sharareh MoghimDepartment of Bacteriology and Virology, Faculty of Medicine, Isfahan University of Medical Science, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Methods: Samples were collected from 66 patients with DFU. The prevalence of Results: The highest levels of resistance were seen against ciprofloxacin, tobramycin, and imipenem, with 58.6%, 57.1%, and 55.1%, respectively. A total of 41.3% and 62.5% of the isolates were strong biofilm-producers and multidrug-resistant, respectively. The prevalence of Conclusion: These findings suggest that all clonal types were associated with the same hospital, emphasizing the need for epidemiologic surveillance of hygiene practices within healthcare facilities to mitigate strain dissemination.

Indexed as

Beta-lactamaseDiabeticFoot ulcermucAPseudomonas aeruginosatoxA

Identifiers

PMID39926042
PMCPMC11803867

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.